Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathy Miller

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Psycho-Oncology|December 27, 2005
The implementation of an oncologist referred, exercise self-management program for older breast cancer survivorsTeresa M Damush, Anthony Perkins, Kathy Miller
Clinical Advances in Hematology & Oncology : H&O|June 4, 2008
Incorporating the Oncotype DX breast cancer assay into community practice: An expert Q & A and case study samplingEleftherios Mamounas, G Thomas Budd, Kathy Miller
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Using a Neoadjuvant Approach for Evaluating Novel Therapies for Patients With Breast CancerNeelima Denduluri, Kathy Miller, Ruth M O'Regan
Breast (Edinburgh, Scotland)|August 21, 2007
Angiogenesis as targeted breast cancer therapyDaniel F Hayes, Kathy Miller, George Sledge
Breast Cancer Research and Treatment|August 30, 2011
Survival-adjusted health-related quality of life (HRQL) among patients with metastatic breast cancer receiving paclitaxel plus bevacizumab versus paclitaxel alone: results from Eastern Cooperative Oncology Group Study 2100 (E2100)David Cella, Molin Wang, Lynne Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Independent review of E2100: a phase III trial of bevacizumab plus paclitaxel versus paclitaxel in women with metastatic breast cancerRobert Gray, Suman Bhattacharya, Christopher Bowden, et al.
Fertility and Sterility|February 19, 2008
Noninvasive metabolomic profiling of human embryo culture media using Raman spectroscopy predicts embryonic reproductive potential: a prospective blinded pilot studyRichard Scott, Emre Seli, Kathy Miller, et al.
Cancer Chemotherapy and Pharmacology|March 5, 2011
Phase I trial of metronomic oral vinorelbine in patients with advanced cancerLakshmi Rajdev, Abdissa Negassa, Qun Dai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2025
Bringing Trustworthy Artificial Intelligence to the Clinical Forefront at <i>JCO</i>: A Guide for Studies Testing Artificial Intelligence ModelsRavi B Parikh, Alexia Iasonos, Andrew Ko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597Gregory A Masters, Lieven Declerck, Charles Blanke, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Psycho-Oncology|December 27, 2005
The implementation of an oncologist referred, exercise self-management program for older breast cancer survivorsTeresa M Damush, Anthony Perkins, Kathy Miller
Clinical Advances in Hematology & Oncology : H&O|June 4, 2008
Incorporating the Oncotype DX breast cancer assay into community practice: An expert Q & A and case study samplingEleftherios Mamounas, G Thomas Budd, Kathy Miller
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Using a Neoadjuvant Approach for Evaluating Novel Therapies for Patients With Breast CancerNeelima Denduluri, Kathy Miller, Ruth M O'Regan
Breast (Edinburgh, Scotland)|August 21, 2007
Angiogenesis as targeted breast cancer therapyDaniel F Hayes, Kathy Miller, George Sledge
Breast Cancer Research and Treatment|August 30, 2011
Survival-adjusted health-related quality of life (HRQL) among patients with metastatic breast cancer receiving paclitaxel plus bevacizumab versus paclitaxel alone: results from Eastern Cooperative Oncology Group Study 2100 (E2100)David Cella, Molin Wang, Lynne Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Independent review of E2100: a phase III trial of bevacizumab plus paclitaxel versus paclitaxel in women with metastatic breast cancerRobert Gray, Suman Bhattacharya, Christopher Bowden, et al.
Fertility and Sterility|February 19, 2008
Noninvasive metabolomic profiling of human embryo culture media using Raman spectroscopy predicts embryonic reproductive potential: a prospective blinded pilot studyRichard Scott, Emre Seli, Kathy Miller, et al.
Cancer Chemotherapy and Pharmacology|March 5, 2011
Phase I trial of metronomic oral vinorelbine in patients with advanced cancerLakshmi Rajdev, Abdissa Negassa, Qun Dai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2025
Bringing Trustworthy Artificial Intelligence to the Clinical Forefront at <i>JCO</i>: A Guide for Studies Testing Artificial Intelligence ModelsRavi B Parikh, Alexia Iasonos, Andrew Ko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597Gregory A Masters, Lieven Declerck, Charles Blanke, et al.
Pageof 5